Impax Laboratories Inc (IPXL)

30.65
0.21 0.69
NASDAQ : Health Care
Prev Close 30.44
Open 30.39
Day Low/High 30.17 / 30.87
52 Wk Low/High 27.62 / 50.74
Volume 590.02K
Avg Volume 660.90K
Exchange NASDAQ
Shares Outstanding 73.81M
Market Cap 2.25B
EPS 0.60
P/E Ratio 61.06
Div & Yield N.A. (N.A)

Latest News

Teva Inches Closer to Completion of Allergan Generics Deal

Teva Inches Closer to Completion of Allergan Generics Deal

Australia's Mayne will shell out $652 million for a basket of generics products from Teva as the latter works to complete its pending Allergan generics purchase.

Impax Laboratories (IPXL) Marked As A Dead Cat Bounce Stock

Impax Laboratories (IPXL) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a "dead cat bounce" (down big yesterday but up big today) candidate

What Exactly Did Allergan and Teva Sell to Impax?

What Exactly Did Allergan and Teva Sell to Impax?

The deal helps the Israeli drug giant comply with required antitrust divestitures connected to completion of its $40.5 billion acquisition of the generics business of Allergan.

Impax (IPXL) Stock Tumbles on Teva, Allergan Generic Drug Deal

Impax (IPXL) Stock Tumbles on Teva, Allergan Generic Drug Deal

Impax Laboratories (IPXL) stock is plunging after the company agreed to buy a portfolio of generic drugs from Teva Pharmaceuticals (TEVA) and Allergan (AGN) for $586 million.

Impax Laboratories (IPXL) Highlighted As Weak On High Volume

Impax Laboratories (IPXL) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a weak on high relative volume candidate

Impax Signs Definitive Agreements To Acquire Generic Products

Impax Signs Definitive Agreements To Acquire Generic Products

- Transaction Expected to Enhance Earnings Growth Potential -

Impax Announces Availability Of EMVERM™ (mebendazole) Chewable Tablets, 100 Mg

Impax Announces Availability Of EMVERM™ (mebendazole) Chewable Tablets, 100 Mg

EMVERM Provides a New Option for Patients with Pinworm, Whipworm, Roundworm and Hookworm in Single or Mixed Infections

4 More Good 'Chicken Shorts'

These overpriced stocks lend themselves to puts or put spreads.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CAG, CCBG, CREE, ESRT, MLNX, MPX, PDCO, TMUS, VSAT, WMT Downgrades: BKU, FFIN, INSY, IPXL, LM, MGLN, MRC, THC Initiations: ONDK, VLRS Read on to get TheStreet Quant Ratings' detailed report:

Impax Laboratories (IPXL) Stock Drops Despite Earnings Beat

Impax Laboratories (IPXL) Stock Drops Despite Earnings Beat

Impax Laboratories (IPXL) stock is declining on Monday after posting its 2015 fourth quarter results before today’s opening bell.

Impax Receives Approval Of EMVERM™ (mebendazole) Chewable Tablets, 100 Mg

Impax Receives Approval Of EMVERM™ (mebendazole) Chewable Tablets, 100 Mg

EMVERM Provides a New Option for Patients with Pinworm, Whipworm, Roundworm and Hookworm in Single or Mixed Infections

Impax Laboratories (IPXL) Strong on High Relative Volume Today

Impax Laboratories (IPXL) Strong on High Relative Volume Today

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a strong on high relative volume candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AZN, HZO, IPXL, SCAI, YY Downgrades: ADUS, CS, CSTE, EEI, FDUS, FNV, MDU, MSON, PEGI, TRC Initiations: HYH Read on to get TheStreet Quant Ratings' detailed report:

Perilous Reversal Watch: Impax Laboratories (IPXL)

Perilous Reversal Watch: Impax Laboratories (IPXL)

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a "perilous reversal" (up big yesterday but down big today) candidate

Impax Laboratories (IPXL) Flagged As Strong On High Volume

Impax Laboratories (IPXL) Flagged As Strong On High Volume

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a strong on high relative volume candidate